Skip to main content

Table 2 Analysis of metastatic lung nodules according to control and treatment groups.

From: Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2

Groups Areas of metastatic nodule (mean, mm2) p-value
Control 0.61–4.04 (1.09) -
Celecoxib 25 mg/kg 0.05–3.81 (1.48) 0.3607
Celecoxib 75 mg/kg 0.07–1.37 (0.81) 0.0295
RT 0.20–0.45 (0.31) 0.0181
RT + Celecoxib 25 mg/kg 0.04–1.64 (0.50) 0.0238
RT + Celecoxib 75 mg/kg 0.03–0.22 (0.13) 0.0675
  1. RT: radiation